Pub Date : 2022-09-01Epub Date: 2022-07-29DOI: 10.1002/syn.22248
Bhagaban Mallik, Sajad Bhat, Vimlesh Kumar
Several proteins contain signaling domains that can regulate the cell membrane dynamics as well as the underlying cytoskeleton. Among these, Bin-Amphiphysin-Rvs (BAR) domain-containing proteins, with their membrane deforming properties, have emerged as the key players in regulating neuronal morphology and inducing neuronal signaling that can modulate synaptic architecture. While the biochemical and structural basis of membrane deformation by the BAR-domain proteins has been extensively studied, the in vivo contexts in which these proteins function remain to be elucidated. Despite the discovery of BAR-domain proteins over 25 years ago, most of the studies have primarily focused on understanding the structural and biochemical properties and cell biological processes regulated by these proteins. Understanding the functional requirements of these proteins at the level of multicellular organisms and the way these proteins regulate biological processes remains a topic of intensive study. In this review, we discuss the functional roles of BAR-domain proteins in the context of membrane dynamics and cellular signaling. We highlight recent developments describing the functional role of these proteins in neuronal morphogenesis, synaptic function, and disease.
{"title":"Role of Bin-Amphiphysin-Rvs (BAR) domain proteins in mediating neuronal signaling and disease.","authors":"Bhagaban Mallik, Sajad Bhat, Vimlesh Kumar","doi":"10.1002/syn.22248","DOIUrl":"https://doi.org/10.1002/syn.22248","url":null,"abstract":"<p><p>Several proteins contain signaling domains that can regulate the cell membrane dynamics as well as the underlying cytoskeleton. Among these, Bin-Amphiphysin-Rvs (BAR) domain-containing proteins, with their membrane deforming properties, have emerged as the key players in regulating neuronal morphology and inducing neuronal signaling that can modulate synaptic architecture. While the biochemical and structural basis of membrane deformation by the BAR-domain proteins has been extensively studied, the in vivo contexts in which these proteins function remain to be elucidated. Despite the discovery of BAR-domain proteins over 25 years ago, most of the studies have primarily focused on understanding the structural and biochemical properties and cell biological processes regulated by these proteins. Understanding the functional requirements of these proteins at the level of multicellular organisms and the way these proteins regulate biological processes remains a topic of intensive study. In this review, we discuss the functional roles of BAR-domain proteins in the context of membrane dynamics and cellular signaling. We highlight recent developments describing the functional role of these proteins in neuronal morphogenesis, synaptic function, and disease.</p>","PeriodicalId":22131,"journal":{"name":"Synapse","volume":"76 11-12","pages":"e22248"},"PeriodicalIF":2.3,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40532561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Treviño, Guadalupe Pulido, Estefania Fuentes, Anabella Handal-Silva, A. Moreno-Rodríguez, Berenice Venegas, Gonzalo Flores, J. Guevara, Alfonso Díaz
Cadmium (Cd) is a heavy metal classified as a carcinogen whose exposure could affect the function of the central nervous system. Studies suggest that Cd modifies neuronal morphology in the hippocampus and affects cognitive tasks. The oxidative stress pathway is proposed as a mechanism of toxicity. However, this mechanism is not precise yet. This study aimed to evaluate the effect of Cd administration on oxidative stress markers in the male rat's hippocampus. Male Wistar rats were divided into (1) control (drinking water) and (2) treatment with Cd (32.5 ppm of cadmium chloride (CdCl2) in water). The Cd was administered for 2, 3, and 4 months. The results show that the oral administration of CdCl2 increased the concentration of Cd in plasma and hippocampus, and this response is time‐dependent on its administration. Likewise, it caused an increase in lipid peroxidation and nitrosative stress markers.
{"title":"Effect of cadmium administration on the antioxidant system and neuronal death in the hippocampus of rats","authors":"S. Treviño, Guadalupe Pulido, Estefania Fuentes, Anabella Handal-Silva, A. Moreno-Rodríguez, Berenice Venegas, Gonzalo Flores, J. Guevara, Alfonso Díaz","doi":"10.1002/syn.22242","DOIUrl":"https://doi.org/10.1002/syn.22242","url":null,"abstract":"Cadmium (Cd) is a heavy metal classified as a carcinogen whose exposure could affect the function of the central nervous system. Studies suggest that Cd modifies neuronal morphology in the hippocampus and affects cognitive tasks. The oxidative stress pathway is proposed as a mechanism of toxicity. However, this mechanism is not precise yet. This study aimed to evaluate the effect of Cd administration on oxidative stress markers in the male rat's hippocampus. Male Wistar rats were divided into (1) control (drinking water) and (2) treatment with Cd (32.5 ppm of cadmium chloride (CdCl2) in water). The Cd was administered for 2, 3, and 4 months. The results show that the oral administration of CdCl2 increased the concentration of Cd in plasma and hippocampus, and this response is time‐dependent on its administration. Likewise, it caused an increase in lipid peroxidation and nitrosative stress markers.","PeriodicalId":22131,"journal":{"name":"Synapse","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48992992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicole Goldfeder, Riley McDonald, Sarah Gaston, Amarri Harrison, Dong-Ho Kim, C. MacIntosh, Mauricio Moel Miranda, Emma Odom, Simmi Nishad, W. Siwik, Liangzhu Zhang, Jen-Wei Lin
4‐aminopyridine (4‐AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert–Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4‐AP at such low concentration selectively blocks a subset of channels in Kv1 or Kv3 families. The crayfish opener neuromuscular junction and ventral superficial flexor (VSF) preparations were used to examine functions of K+ channels blocked by low concentrations of 4‐AP. At opener motor axons, intracellular recordings show that 4‐AP could increase action potential (AP) amplitude, duration, and after‐depolarization (ADP) at 10 μM. As 4‐AP concentration was increased, in twofold steps, AP amplitude did not increase further up to 5 mM. AP duration and ADP increased significantly mainly in two concentration ranges, 10–50 μM and 1–5 mM. The effects of 50 μM 4‐AP on the VSF were less consistent than that observed at the opener motor axons. 4‐AP did not change AP amplitude of motor axons recorded with an extracellular electrode and change in AP repolarizing potential was observed in ∼25% of the axons. EPSP recorded simultaneously with AP showed an increase in amplitude with 4‐AP treatment only in 30% of the axon‐EPSP pairs. 4‐AP also increased firing frequencies of ∼50% of axons. In four animals, 4‐AP “awakened” the firing of APs from an axon that was silent before the drug. The mixture of positive and negative 4‐AP effects summarized above was observed in the same VSF preparations in all cases (n = 8). We propose that there is a significant diversity in the density 4‐AP‐sensitive potassium channels among motor axons of the VSF. Functional significance in the differences of 4‐AP sensitivity of the two motor systems is discussed.
{"title":"Functions of potassium channels blocked by low micromolar 4‐aminopyridine in the crayfish nervous system","authors":"Nicole Goldfeder, Riley McDonald, Sarah Gaston, Amarri Harrison, Dong-Ho Kim, C. MacIntosh, Mauricio Moel Miranda, Emma Odom, Simmi Nishad, W. Siwik, Liangzhu Zhang, Jen-Wei Lin","doi":"10.1002/syn.22234","DOIUrl":"https://doi.org/10.1002/syn.22234","url":null,"abstract":"4‐aminopyridine (4‐AP) is a potassium channel blocker that has been used to treat patients with multiple sclerosis and Lambert–Eaton disease. The concentration of this drug in the blood of patients was estimated to be in low or submicromolar range. Animal studies have shown that 4‐AP at such low concentration selectively blocks a subset of channels in Kv1 or Kv3 families. The crayfish opener neuromuscular junction and ventral superficial flexor (VSF) preparations were used to examine functions of K+ channels blocked by low concentrations of 4‐AP. At opener motor axons, intracellular recordings show that 4‐AP could increase action potential (AP) amplitude, duration, and after‐depolarization (ADP) at 10 μM. As 4‐AP concentration was increased, in twofold steps, AP amplitude did not increase further up to 5 mM. AP duration and ADP increased significantly mainly in two concentration ranges, 10–50 μM and 1–5 mM. The effects of 50 μM 4‐AP on the VSF were less consistent than that observed at the opener motor axons. 4‐AP did not change AP amplitude of motor axons recorded with an extracellular electrode and change in AP repolarizing potential was observed in ∼25% of the axons. EPSP recorded simultaneously with AP showed an increase in amplitude with 4‐AP treatment only in 30% of the axon‐EPSP pairs. 4‐AP also increased firing frequencies of ∼50% of axons. In four animals, 4‐AP “awakened” the firing of APs from an axon that was silent before the drug. The mixture of positive and negative 4‐AP effects summarized above was observed in the same VSF preparations in all cases (n = 8). We propose that there is a significant diversity in the density 4‐AP‐sensitive potassium channels among motor axons of the VSF. Functional significance in the differences of 4‐AP sensitivity of the two motor systems is discussed.","PeriodicalId":22131,"journal":{"name":"Synapse","volume":"76 1","pages":""},"PeriodicalIF":2.3,"publicationDate":"2022-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50871907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01Epub Date: 2022-02-13DOI: 10.1002/syn.22226
Kyoungjune Pak, Seongho Seo, Myung Jun Lee, Hyung-Jun Im, Keunyoung Kim, In Joo Kim
Dopamine transporters (DAT) are transmembrane proteins that translocate dopamine from the extracellular space into presynaptic neurons. We aimed to investigate the predictive power of DAT mRNA for DAT protein expression, measured using positron emission tomography (PET). We performed 18 F-FP-CIT PET scans in 35 healthy individuals. Binding potentials (BPND ) from the ventral striatum, caudate nucleus, putamen, and middle frontal, orbitofrontal, cingulate, parietal, and temporal cortices were measured. DAT gene expression data were obtained from the freely available Allen Human Brain Atlas derived from six healthy donors. The auto-correlation of PET-derived BPND s for DAT was intermediate (mean ρ2 = .66) with ρ2 ranging from .0811 to 1. However, the auto-correlation of mRNA expression was weak across the probes with a mean ρ2 of .09-.23. Cross-correlations between PET-derived BPND s and mRNA expression were weak with a mean ρ2 ranging from 0 to .22 across the probes. In conclusion, we observed weak associations between DAT mRNA expression and DAT availability in human brains. Therefore, DAT mRNA mapping may have only limited predictive power for DAT availability in humans. However, the difference in distribution of DAT mRNA and DAT protein may influence this limitation.
{"title":"Limited power of dopamine transporter mRNA mapping for predicting dopamine transporter availability.","authors":"Kyoungjune Pak, Seongho Seo, Myung Jun Lee, Hyung-Jun Im, Keunyoung Kim, In Joo Kim","doi":"10.1002/syn.22226","DOIUrl":"https://doi.org/10.1002/syn.22226","url":null,"abstract":"<p><p>Dopamine transporters (DAT) are transmembrane proteins that translocate dopamine from the extracellular space into presynaptic neurons. We aimed to investigate the predictive power of DAT mRNA for DAT protein expression, measured using positron emission tomography (PET). We performed <sup>18</sup> F-FP-CIT PET scans in 35 healthy individuals. Binding potentials (BP<sub>ND</sub> ) from the ventral striatum, caudate nucleus, putamen, and middle frontal, orbitofrontal, cingulate, parietal, and temporal cortices were measured. DAT gene expression data were obtained from the freely available Allen Human Brain Atlas derived from six healthy donors. The auto-correlation of PET-derived BP<sub>ND</sub> s for DAT was intermediate (mean ρ<sup>2</sup> = .66) with ρ<sup>2</sup> ranging from .0811 to 1. However, the auto-correlation of mRNA expression was weak across the probes with a mean ρ<sup>2</sup> of .09-.23. Cross-correlations between PET-derived BP<sub>ND</sub> s and mRNA expression were weak with a mean ρ<sup>2</sup> ranging from 0 to .22 across the probes. In conclusion, we observed weak associations between DAT mRNA expression and DAT availability in human brains. Therefore, DAT mRNA mapping may have only limited predictive power for DAT availability in humans. However, the difference in distribution of DAT mRNA and DAT protein may influence this limitation.</p>","PeriodicalId":22131,"journal":{"name":"Synapse","volume":"76 5-6","pages":"e22226"},"PeriodicalIF":2.3,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39575984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01Epub Date: 2022-02-25DOI: 10.1002/syn.22227
Vasilii Shteinikov, Konstantin Evlanenkov, Konstantin Bolshakov, Denis Tikhonov
Acid-sensing ion channels (ASICs) participate in synaptic transmission due to the acidic content of synaptic vesicles, but their contribution to postsynaptic currents is small. This has stimulated attempts to find endogenous ASIC potentiators that could enhance ASIC-mediated currents to physiologically relevant values. Here we demonstrate that glutamate, which serves as a neurotransmitter, potentiates recombinant ASIC1a in the submillimolar concentration range. The effect of glutamate is especially interesting as ASIC's presence has been shown in glutamatergic synapses. At pH=6.5 glutamate had maximum potentiation of 87% with an EC50 value of 0.65 mM. The mechanism of potentiation is due to a shift of pH-dependent activation to less acidic values, with 0.5 mM glutamate increasing pH50 from 6.04 to 6.43. Due to this mechanism, ASIC1a in glutamatergic synapses might be intrinsically potentiated. Furthermore, this effect could compensate for the inhibition of ionotropic glutamate receptors by extracellular acidification during synaptic transmission.
{"title":"Glutamate potentiates heterologously expressed homomeric acid-sensing ion channel 1a.","authors":"Vasilii Shteinikov, Konstantin Evlanenkov, Konstantin Bolshakov, Denis Tikhonov","doi":"10.1002/syn.22227","DOIUrl":"https://doi.org/10.1002/syn.22227","url":null,"abstract":"<p><p>Acid-sensing ion channels (ASICs) participate in synaptic transmission due to the acidic content of synaptic vesicles, but their contribution to postsynaptic currents is small. This has stimulated attempts to find endogenous ASIC potentiators that could enhance ASIC-mediated currents to physiologically relevant values. Here we demonstrate that glutamate, which serves as a neurotransmitter, potentiates recombinant ASIC1a in the submillimolar concentration range. The effect of glutamate is especially interesting as ASIC's presence has been shown in glutamatergic synapses. At pH=6.5 glutamate had maximum potentiation of 87% with an EC<sub>50</sub> value of 0.65 mM. The mechanism of potentiation is due to a shift of pH-dependent activation to less acidic values, with 0.5 mM glutamate increasing pH<sub>50</sub> from 6.04 to 6.43. Due to this mechanism, ASIC1a in glutamatergic synapses might be intrinsically potentiated. Furthermore, this effect could compensate for the inhibition of ionotropic glutamate receptors by extracellular acidification during synaptic transmission.</p>","PeriodicalId":22131,"journal":{"name":"Synapse","volume":"76 5-6","pages":"e22227"},"PeriodicalIF":2.3,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39624320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Avendaño-Estrada, L. Verdugo-Dı́az, M. Ávila-Rodríguez
Animal models of Parkinson's disease are useful to evaluate new treatments and to elucidate the etiology of the disease. Hence, it is necessary to have methods that allow quantification of their effectiveness. [18F]FDOPA‐PET (FDOPA‐PET) imaging is outstanding for this purpose because of its capacity to measure changes in the dopaminergic pathway noninvasively and in vivo. Nevertheless, PET acquisition and quantification is time‐consuming making it necessary to find faster ways to quantify FDOPA‐PET data. This study evaluated Male Wistar rats by FDOPA, before and after being partially injured with 6‐OHDA unilaterally. MicroPET scans with a duration of 120 min were acquired and Patlak reference plots were created to estimate the influx constant Kc in the striatum using the full dynamic scan data. Additionally, simple striatal‐to‐cerebral ratios (SCR) of short static acquisitions were computed and compared with the Kc values. Good correlation (r > 0.70) was obtained between Kc and SCR, acquired between 80–120 min after FDOPA administration with frames of 10 or 20 min and both methods were able to separate the FDOPA‐uptake of healthy controls from that of the PD model (SCR −28%, Kc −71%). The present study concludes that Kc and SCR can be trustfully used to discriminate partially lesioned rats from healthy controls.
{"title":"Comparative analysis of striatal [18F]FDOPA uptake in a partial lesion model of Parkinson's disease in rats: Ratio method versus graphical model","authors":"A. Avendaño-Estrada, L. Verdugo-Dı́az, M. Ávila-Rodríguez","doi":"10.1002/syn.22231","DOIUrl":"https://doi.org/10.1002/syn.22231","url":null,"abstract":"Animal models of Parkinson's disease are useful to evaluate new treatments and to elucidate the etiology of the disease. Hence, it is necessary to have methods that allow quantification of their effectiveness. [18F]FDOPA‐PET (FDOPA‐PET) imaging is outstanding for this purpose because of its capacity to measure changes in the dopaminergic pathway noninvasively and in vivo. Nevertheless, PET acquisition and quantification is time‐consuming making it necessary to find faster ways to quantify FDOPA‐PET data. This study evaluated Male Wistar rats by FDOPA, before and after being partially injured with 6‐OHDA unilaterally. MicroPET scans with a duration of 120 min were acquired and Patlak reference plots were created to estimate the influx constant Kc in the striatum using the full dynamic scan data. Additionally, simple striatal‐to‐cerebral ratios (SCR) of short static acquisitions were computed and compared with the Kc values. Good correlation (r > 0.70) was obtained between Kc and SCR, acquired between 80–120 min after FDOPA administration with frames of 10 or 20 min and both methods were able to separate the FDOPA‐uptake of healthy controls from that of the PD model (SCR −28%, Kc −71%). The present study concludes that Kc and SCR can be trustfully used to discriminate partially lesioned rats from healthy controls.","PeriodicalId":22131,"journal":{"name":"Synapse","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2022-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44064652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-01Epub Date: 2022-02-14DOI: 10.1002/syn.22224
Nathan Gock, Jordan Follett, Gordon L Rintoul, Timothy V Beischlag, Frank J S Lee
The retromer complex is an evolutionarily conserved protein complex involved in the endosomal recycling of various cargo proteins. It is ubiquitously expressed in all tissue and is found in both invertebrate as well as mammalian nervous systems, where it recycles various synaptic membrane proteins including the dopamine transporter and dopamine D1 receptor, two proteins implicated in dopamine homeostasis and neurotransmission. The involvement of the retromer complex in dopamine neurobiology is further underscored by its links to Parkinson's disease, a neurodegenerative disorder of the dopamine system. In this article, the existing literature linking the retromer complex to synaptic function and dopamine homeostasis is reviewed. Additional possible links are highlighted by exploring the retromer and other Parkinson's disease-associated proteins and possible relationships to synaptic function and dopamine transmission.
{"title":"Endosomal recycling and dopamine neurotransmission: Exploring the links between the retromer and Parkinson's disease.","authors":"Nathan Gock, Jordan Follett, Gordon L Rintoul, Timothy V Beischlag, Frank J S Lee","doi":"10.1002/syn.22224","DOIUrl":"https://doi.org/10.1002/syn.22224","url":null,"abstract":"<p><p>The retromer complex is an evolutionarily conserved protein complex involved in the endosomal recycling of various cargo proteins. It is ubiquitously expressed in all tissue and is found in both invertebrate as well as mammalian nervous systems, where it recycles various synaptic membrane proteins including the dopamine transporter and dopamine D1 receptor, two proteins implicated in dopamine homeostasis and neurotransmission. The involvement of the retromer complex in dopamine neurobiology is further underscored by its links to Parkinson's disease, a neurodegenerative disorder of the dopamine system. In this article, the existing literature linking the retromer complex to synaptic function and dopamine homeostasis is reviewed. Additional possible links are highlighted by exploring the retromer and other Parkinson's disease-associated proteins and possible relationships to synaptic function and dopamine transmission.</p>","PeriodicalId":22131,"journal":{"name":"Synapse","volume":"76 3-4","pages":"e22224"},"PeriodicalIF":2.3,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39737540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}